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Takaaki Jo6, Yasuyuki Sumida7, Nobunaga Okada1,8, Masahiro Nozawa9, Ayumu Tsuruoka10,11, Yoshihiro Fujimoto3,
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Abstract
Background: Accidental hypothermia (AH) is defined as an involuntary decrease in core body temperature to
< 35 °C. The management of AH has been progressing over the last few decades, and numerous techniques for
rewarming have been validated. However, little is known about the association between rewarming rate (RR) and
mortality in patients with AH.
Method: This was a multicentre chart review study of patients with AH visiting the emergency department of 12
institutions in Japan from April 2011 to March 2016 (Japanese accidental hypothermia network registry, J-Point
registry). We retrospectively registered patients using the International Classification of Diseases, Tenth Revision
code T68: ‘hypothermia’. We excluded patients whose body temperatures were unknown or ≥ 35 °C, who could not
be rewarmed, whose rewarmed temperature or rewarming time was unknown, those aged < 18 years, or who or
whose family members had refused to join the registry. RR was calculated based on the body temperature on
arrival at the hospital, time of arrival at the hospital, the documented temperature during rewarming, and time of
the temperature documentation. RR was classified into the following five groups: ≥2.0 °C/h, 1.5–< 2.0 °C/h, 1.0–
< 1.5 °C/h, 0.5–< 1.0 °C/h, and < 0.5 °C/h. The primary outcome of this study was in-hospital mortality. The association
between RR and in-hospital mortality was evaluated using multivariate logistic regression analysis.
Result: During the study, 572 patients were registered in the J-Point registry, and 481 patients were included
in the analysis. The median body temperature on arrival to the hospital was 30.7 °C (interquartile range [IQR],
28.2 °C–32.4 °C), and the median RR was 0.85 °C/h (IQR, 0.53 °C/h–1.31 °C/h). The in-hospital mortality rates
were 19.3% (11/57), 11.1% (4/36), 14.4% (15/104), 20.1% (35/175), and 34.9% (38/109) in the ≥2.0 °C/h,
1.5–< 2.0 °C/h, 1.0–< 1.5 °C/h, 0.5–< 1.0 °C/h, and < 0.5 °C/h groups, respectively. Multivariate regression analysis
revealed that in-hospital mortality rate increased with each 0.5 °C/h decrease in RR (adjusted odds ratio, 1.49;
95% confidence interval, 1.15–1.94; Ptrend < 0.01).
Conclusion: This study showed that slower RR is independently associated with in-hospital mortality.
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Background
Accidental hypothermia (AH) is defined as an involun-
tary decrease in core body temperature to < 35 °C [1].
AH cases are frequently observed in the emergency de-
partment and can present significant problems. A pre-
vious study has stated that the mortality rate of patients
with AH was as high as approximately 30% [2]. Severe
hypothermia (body core temperature < 28 °C) was specif-
ically associated with a high risk of sudden cardiac arrest
[3]. The management of AH has been progressing over
the last few decades, and numerous techniques for
rewarming have been validated [4–6]; however, little is
known about the optimal rewarming rate (RR).
Theoretically, it seems reasonable to rewarm patients
with AH as fast as possible to avoid the fatal complica-
tions of hypothermia such as cardiac instability [1, 5].
Conversely, rewarming is associated with a number of
complications: for example, hypotension, neutropenia,
thrombocytopenia, electrolyte changes, cardiac arrhyth-
mias, gastrointestinal bleeding, and infection [4, 6–9].
These complications may consequently affect the mor-
tality rate as a number of deaths in patients with AH
have been noted after successful rewarming [6]. Hence,
the selection of appropriate rewarming strategies, includ-
ing RR, is considered the major problem in AH. Sugges-
tions about RR vary among studies; some studies suggest
the benefit of rapid RR [4, 5, 10], while other studies do
not [6, 11–13]. These suggestions are based on small ob-
servational studies, animal studies, and studies in cardiac
surgery. Thus, existing guidelines do not mention the
optimal RR because of insufficient evidence [1, 3].
We performed the Japanese accidental hypothermia
network registry (J-Point registry), a multicentre retro-
spective observational study, which enrolled 481 adult
patients with AH. Using this registry, we evaluated the
association between RR and in-hospital mortality.
Methods
Study design and setting
We conducted a multicentre chart review study of patients
with AH visiting the emergency departments of 12 institu-
tions in Japan (Japanese accidental hypothermia network
registry [J-Point registry]). The Japanese AH network com-
prises eight critical care medical centres (CCMCs) and four
non-CCMCs with an emergency department across the
Kyoto, Osaka, and Shiga Prefectures in Japan. For the par-
ticipating institutions, the median annual emergency de-
partment visit volume was 19,651 (interquartile range
[IQR], 13,281–27,554). Using these data, we evaluated the
association between RR and mortality.
Participants
We retrospectively registered patients using the Inter-
national Classification of Diseases, Tenth Revision (ICD-
10) code T68: ‘hypothermia’ from April 2011 to March
2016. We excluded patients whose body temperatures
were unknown or ≥ 35 °C, who could not be rewarmed,
whose rewarmed temperature or rewarming time was
unknown, aged < 18 years, or those who or whose family
members had refused to join the registry.
Data collection and quality control
The details of the methodology were described pre-
viously [14]. In summary, all chart reviewers were
emergency physicians who underwent training for
appropriate data extraction. A predefined uniform data-
sheet was used for data collection.
Collected baseline patient characteristics were as fol-
lows: sex, age, activities of daily living (ADLs) before the
emergency department visit (independent, needing some
assistance, or needing total assistance), residence (living
at home alone, living at home but not alone, nursing
home, or homeless), medical history (cardiovascular dis-
ease, neurological disease, endocrine disease, psychiatric
disease, malignant disease, or dementia, or others), loca-
tion (indoor or outdoor), and mode of arrival (walk-in or
transported using an ambulance).
The data collected upon arrival at the hospital were
as follows: vital signs upon arrival at the hospital
(body temperature, blood pressure, heart rate, and
Glasgow Coma Scale [GCS] score), biological data
(serum pH, bicarbonate [HCO3-] [mEq/L], lactate
[mmol/L], sodium [mEq/L], potassium [mEq/L], and
glucose [mg/dL] levels), cold exposure, associated
conditions, treatment process, and outcome. The
presence of cold exposure, which is a possible cause
of the hypothermia, was determined by the clinician
who cared for the patient or who entered the data of
this study. The Sequential Organ Failure Assessment
(SOFA) score was only calculated for patients admit-
ted to the intensive care unit. Consistent with a pre-
vious study [2], associated conditions were classified
into internal disease, traumatic injury, alcohol intoxi-
cation, drowning, and self-harm, and others. The
diagnoses of internal disease were obtained from
ICD-9 or ICD-10 code in the medical records.
Rewarming procedures were divided into active exter-
nal/minimally invasive rewarming (warm intravenous
fluids, warm blanket, forced warm air, heating pads,
and warm bath) and active internal rewarming (lav-
age, intravascular haemodialysis, and extracorporeal
membrane oxygenation) [15]. Other treatment infor-
mation included endotracheal intubation, use of cate-
cholamines, and emergent transvenous cardiac pacing.
The data collected on the outcomes were in-hospital
mortality and the incidence of ventricular fibrillation
or pulseless ventricular tachycardia (VF/VT).
Watanabe et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine          (2019) 27:105 Page 2 of 10
Outcome measures
In this study, the primary outcome was in-hospital mor-
tality, and the secondary outcome was the incidence of
VF/VT. We calculated RR based on the body
temperature upon arrival, documented temperature dur-
ing rewarming, and time spent for the rewarming. We
evaluated the association between RR and these
outcomes.
Statistical analysis
Patients were divided into the following five groups ac-
cording to their RR: ≥2.0 °C/h, 1.5–< 2.0 °C/h, 1.0–<
1.5 °C/h, 0.5–< 1.0 °C/h, and < 0.5 °C/h. Patients’ charac-
teristics, in-hospital information, and outcomes were
evaluated between the five groups using Kruskal-Wallis
tests for continuous variables and Fisher’s exact tests for
categorical variables. For the post-hoc analyses of these
tests, Steel-Dwass multiple comparison tests and Bonfer-
roni correction for multiple comparisons were used, re-
spectively. Regarding the primary outcome, the
association between each category of the RR and in-
hospital mortality was evaluated using the univariate and
multivariate logistic regression analyses, with crude or
adjusted odds ratios (AORs) and their 95% confidence
interval (CI) as the effect variables. In multivariate
models, we selected the potential confounders that were
considered to be associated with the clinical outcomes,
including sex, age category (adults aged 18–64 years, the
young–elderly aged 65–74 years, or the elderly–elderly
aged ≥75 years), body temperature at arrival to the
hospital (mild [≥32 °C], moderate [28–32 °C], and severe
[< 28 °C]), the number of past medical history (none,
one, or multiple), ADLs (independent, need for some as-
sistance, need for total assistance, or unknown), systolic
blood pressure (cardiac arrest, unmeasurable, 40–90
mmHg, or 90 <mmHg), cold exposure (yes, no, or un-
known), presence of associated internal diseases (yes or
no), and active internal rewarming (yes or no). Regard-
ing the secondary outcome, the association between
each category of the RR and occurrence of VF/VT was
evaluated using the univariate logistic regression ana-
lyses, with crude odds ratios and their 95% CI as the ef-
fect variables. Additionally, we divided the patients into
subgroups according to age category (adults aged 18–64
years, elderly patients aged ≥65 years), location (indoor,
outdoor), body temperature at arrival to the hospital
(mild, moderate, severe), associated conditions (presence
of associated internal disease or not), and rewarming
procedure (use of active internal rewarming or not). The
association between each category of the RR and in-
hospital mortality was evaluated in the same way as the
primary outcome. All P values were two-sided, and 0.05
levels were considered statistically significant. All statis-
tical analyses were performed using the Statistical
Package for the Social Sciences software (V.24 J), R (The
R Foundation for Statistical Computing, version 3.30,
Saitama, Japan), and EZR (Saitama Medical Center, Jichi
Medical University, version 1.32, Saitama, Japan), which
is a graphical user interface for R [16].
Result
During the study period, 572 patients were registered in
the J-Point registry; out of which, 27 patients whose
body temperature was ≥35 °C, 8 patients aged < 18 years,
2 patients who could not be rewarmed, and 54 patients
whose rewarmed temperature or rewarming time were
unknown were excluded in the study (Fig. 1). We finally
enrolled 481 patients for the analysis.
Patient characteristic and in-hospital data
The baseline patients’ characteristics are presented in
Table 1. Approximately half of the patients were male
(50.5%), and the median age was 79 years (IQR, 67–87
years). Overall, 78% of the patients had AH in an indoor
setting. Patients were younger in the ≥2.0 °C/h group.
Patients in the < 0.5 °C/h groups were more likely to
have decreased ADLs and lived in nursing homes. There
was no significant difference in the number and types of
past medical history among the five groups.
The in-hospital data are presented in Table 2. The me-
dian body temperature was 30.7 °C (IQR, 28.2–32.4 °C),
and the median RR was 0.85 °C/h (IQR, 0.53–1.31 °C/h).
Most of the patients received active external or
minimally invasive rewarming, whereas about one in six
patients received active internal rewarming. The per-
centage of patients with cardiac arrest was highest in the
> 2.0 °C/h group. Acid-base status abnormality (pH, lac-
tate, and HCO3-) are more common in the > 2.0 °C/h
group, but serum sodium and potassium levels did not
differ among the five groups. There was no significant
difference in GCS and SOFA score. The prevalence of
internal disease association was significantly high in the
< 0.5 °C/h group.
Outcome
The outcomes of this study are presented in Table 3.
The in-hospital mortality rates were 19.3% (11/57),
11.1% (4/36), 14.4% (15/104), 20.1% (35/175), and 34.9%
(38/109) in the ≥2.0 °C/h, 1.5–< 2.0 °C/h, 1.0–< 1.5 °C/h,
0.5–< 1.0 °C/h, and < 0.5 °C/h groups, respectively. Multi-
variate regression analysis revealed that the in-hospital
mortality rate increased with each 0.5 °C/h decrease in
RR (AOR, 1.49; 95% CI, 1.15–1.94; Ptrend < 0.01). Add-
itionally, the mortality rate was significantly higher in
the < 0.5 °C/h group than in the ≥2.0 °C/h group (AOR,
4.09; 95% CI, 1.33–12.6). Regarding the case of the sec-
ondary outcome, univariate logistic analysis revealed that
the incidence of VF/VT decreased with each 0.5 °C/h
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decrease in RR (AOR, 0.55; 95% CI, 0.33–0.90; Ptrend =
0.016). According to the subgroup analysis, although
each analysis showed heterogeneity and under power,
the negative association of RR and mortality was
constant (Table 4).
Discussion
In this study, we found that the RR of patients with AH
is independently associated with mortality after adjusting
the important potentially confounding factors. In-
hospital mortality rates increase with each 0.5 °C/h de-
crease in RR. Furthermore, the mortality rate in the <
0.5 °C/h group was significantly higher than that in the
> 2.0 °C/h group. To the best of our knowledge, this is
the first multicentre study to assess the association be-
tween RR and mortality, and the findings of this study
may provide important information regarding the appro-
priate treatment of AH.
We initially show that patients with slower RR have
the following characteristics: are more likely to be older,
have lower body temperature at arrival to the hospital,
and have an internal disease. This result is consistent
with that of the previous studies [6, 17]. However, the
RR in this study was slower than that in the previous
studies because of the older age of our study population
[10]. Another possible reason is the high proportion of
the patients who developed AH in an indoor setting,
which might be the result of underlying diseases such as
infections [18].
Previous studies have suggested a possible association
between RR and mortality. Daniel et al. reported that the
mean RR in patients with AH who died was significantly
slower than that in surviving patients in a retrospective
multicentre observational study [17]. Kathleen et al. re-
ported that the likelihood of mortality was associated
with slower RR in a single-centre observational study,
which included 96 patients [18]. These results are, al-
though not the main outcome of the studies and derived
from univariate analysis, consistent with the results of
our study. In this study, we confirmed the negative asso-
ciation between RR and mortality using multivariate lo-
gistic analysis with 481 patients, which is the largest
sample size in this field.
There are several known physiological effects of
hypothermia that could result in high mortality. Cardiac
contractility and pulse rate decrease as the heart cools
[1, 3, 8]. Cold stress reduces the circulating blood vol-
ume due to cold-induced diuresis, extravascular plasma
shift, and inadequate fluid intake [6, 19, 20]. Both hypo-
and hyper-kalaemia occur in patients with AH due to
the shift of extracellular potassium into the cells, acid-
osis, and cell death [8, 21]. Ventilatory response to
carbon dioxide is attenuated and results in respiratory
acidosis [3, 22]. These cardiorespiratory effects may lead
to the clinical manifestations of shock and dysrhythmia
Fig. 1 Study flowchart
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Table 1 Baseline characteristics of the study population according to their rewarming rate category
All
patients
Rewarming rate (°C/h) P values*
(≥2.0) (1.5–< 2.0) (1.0–< 1.5) (0.5–< 1.0) (< 0.5)
n = 481 n = 57 n = 36 n = 104 n = 175 n = 109
Men 243 (50.5) 25 (43.9) 14 (38.9) 56 (53.8) 93 (53.1) 55 (50.5) 0.424
Age, y, median (IQR) 79 (67–87) 71 (64–81)a, b 77 (68–85) 76 (64–87) 82 (70–87)a 81 (72–89)b 0.002
Age category
Adults aged 18–64 years 101 (21.0) 15 (26.3) 8 (22.2) 27 (26.0) 35 (20.0) 16 (14.7) 0.240
Young-elderly aged 65–74 years 79 (16.4) 18 (31.6)a 7 (19.4) 18 (17.3) 20 (11.4)a 16 (14.7) 0.014
Elderly-elderly aged ≥75 years 301 (62.6) 24 (42.1)a, b 21 (58.3) 59 (56.7) 120 (68.6)a 77 (70.6)b 0.002
Activity of daily living
Independent 335 (70.0) 49 (86.0)a 30 (83.3)b 74 (71.2) 121 (68.4) 61 (56.0)a, b < 0.001
Need for some assistance 114 (23.7) 8 (14.0) 5 (13.9) 28 (26.9) 44 (25.3) 29 (26.6) 0.183
Need for total assistance 31 (6.4) 0 (0.0)a 1 (2.8) 2 (1.9)b 10 (6.3)c 18 (16.5)a, b, c < 0.001
Unknown 1 (0.21) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.9)
Residence
Home 432 (89.8) 53 (93.0) 34 (94.4) 101 (97.1)a 156 (89.1) 88 (80.7)a 0.002
Living alone 193 (40.1) 17 (29.8) 19 (52.8) 51 (49.0)a 75 (42.9) 31 (28.4)a 0.004
Living not alone 239 (49.7) 36 (63.2) 15 (41.7) 50 (48.1) 81 (46.3) 57 (52.3) 0.180
Nursing home 30 (6.2) 0 (0.0)a 1 (2.8) 1 (1.0)b 11 (6.3) 17 (15.6)a, b < 0.001
Homelessness 4 (0.8) 0 (0.0) 1 (2.8) 0 (0.0) 2 (1.1) 1 (0.9) 0.496
Unknown 15 (3.1) 4 (7.0) 0 (0.0) 2 (1.9) 6 (3.4) 3 (2.8)
Location
Indoor 375 (78.0) 36 (63.2)a, b 27 (75.0) 68 (65.4)c, d 150 (85.7)a, c 94 (86.2)b, d < 0.001
Outdoor 106 (22.0) 21 (36.8)a, b 9 (25.0) 36 (34.6)c, d 25 (14.3)a, c 15 (13.8)b, d < 0.001
Mode of arrival
Ambulance 453 (94.2) 55 (96.5) 35 (97.2) 101 (97.1) 166 (94.9) 96 (88.1) 0.065
Walk-in 28 (5.8) 2 (3.5) 1 (2.8) 3 (2.9) 9 (5.1) 13 (11.9) 0.065
Past medical history
Cardiovascular disease 213 (44.3) 27 (47.4) 13 (36.1) 37 (35.6) 77 (44.0) 59 (54.1) 0.070
Neurological disease 86 (17.9) 7 (12.3) 4 (11.1) 21 (20.2) 31 (17.7) 23 (21.1) 0.507
Endocrine disease 116 (24.2) 16 (28.1) 8 (22.2) 18 (17.3) 44 (25.1) 30 (27.5) 0.391
Psychiatric disease 110 (22.9) 18 (31.6) 11 (30.6) 24 (23.1) 37 (21.1) 20 (18.3) 0.261
Malignant disease 50 (10.4) 7 (12.3) 3 (8.3) 9 (8.7) 23 (13.1) 8 (7.3) 0.546
Dementia 99 (20.6) 5 (8.8) 7 (19.4) 20 (19.2) 39 (22.3) 28 (25.7) 0.111
Other 88 (18.7) 7 (12.3) 6 (16.7) 19 (18.3) 35 (20.0) 21 (19.3) 0.784
Unknown 7 (1.46) 1 (1.8) 0 (0.0) 1 (1.0) 3 (1.7) 2 (1.8) 1.000
Number of past medical history
None 118 (24.5) 13 (22.8) 11 (30.6) 28 (26.9) 47 (26.9) 19 (17.4) 0.308
One 152 (31.6) 18 (31.6) 11 (30.6) 37 (35.6) 50 (28.6) 36 (33.0) 0.803
Multiple 211 (43.9) 26 (45.6) 14 (38.9) 39 (37.5) 78 (44.6) 54 (49.5) 0.464
Values are expressed numbers (percentages) unless indicated otherwise
Groups that share a superscript letter were significantly different from post-hoc pairwise comparisons
* Represents P for heterogeneity across the 5 rewarming rate groups. Comparisons between the 5 groups were evaluated with Kruskal-Wallis test for numeric
variables and Fisher’s exact test for categorical variables. For post-hoc pairwise comparisons of these tests, Steel-Dwass multiple comparison tests and Bonferroni
correction for multiple comparisons were used, respectively
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Table 2 In-hospital data of the study population according to their rewarming rate category
All patients Missing Rewarming rate (°C/h) P values*
(≥2.0) (1.5–< 2.0) (1.0–< 1.5) (0.5–< 1.0) (< 0.5)
n = 481 n = 57 n = 36 n = 104 n = 175 n = 109









Body temperature category 0 (0.0)
Mild (≥32 °C) 163 (33.9) 10 (17.5)a 5 (13.9)b 27 (26.0)c 60 (34.3)d 61 (56.0)a, b, c, d < 0.001
Moderate (28–32 °C) 216 (44.9) 15 (26.3)a 16 (44.4) 48 (46.2) 92 (52.6)a 45 (41.3) 0.011
Severe (< 28 °C) 102 (21.2) 32 (56.1)a 15 (41.7)b 29 (27.9)a 23 (13.1)a, b 3 (2.8)a, b < 0.001
Systolic blood pressure 0 (0.0)
Cardiac arrest 12 (2.5) 9 (15.8)a, b, c 0 (0.0) 1 (1.0)a 1 (0.6)b 1 (0.9)c < 0.001
Unmeasurable 29 (6.0) 8 (14.0) 2 (5.6) 4 (3.8) 12 (6.9) 3 (2.8) 0.063
40–90 mmHg 98 (20.4) 5 (8.8)a 8 (22.2) 21 (20.2) 33 (18.9) 31 (28.4)a 0.045
> 90 mmHg 342 (71.1) 35 (61.4) 26 (72.2) 78 (75.0) 129 (73.7) 74 (67.9) 0.345
Heart rate, Median (IQR) 65 (49–84) 2 (0.4) 60 (35–99) 74 (49–95) 71 (58–87)a 63 (50–81) 60 (45–75)a 0.021
Glasgow coma scale, Median (IQR) 11 (8–14) 58
(12.1)
11 (6–13) 11 (8–13) 11 (8–14) 12 (9–14) 10 (7–14) 0.073
Biological data















Serum HCO3- (mEq/L), Median
(IQR)
21 .0 (15.8–25.7) 66
(13.7)
19.9 (14.6–23.9)a 18.3 (15.1–25.6) 19.2 (14.4–
24.0)b
21.9 (16.0–26.2) 22.8 (17.0–26.4)a,
b
0.014




4.4 (2.2–8.8)a, b 3.1 (1.9–5.8)c 4.1 (2.0–7.0)d, e 2.1 (1.2–5.6)a, d 1.8 (0.9–3.6)b, c, e < 0.001
Serum Sodium (mEq/L), Median
(IQR)
140 (135–143) 7 (1.5) 140 (137–143) 141 (139–143) 140 (137–143) 139 (136–143) 138 (133–143) 0.272
Serum Potassium (mEq/L),
Median (IQR)
4 (3.6–4.7) 6 (1.2) 4.2 (3.6–4.9) 4.2 (3.6–4.5) 4.1 (3.6–4.8) 4.0 (3.5–4.6) 4.0 (3.6–4.5) 0.891
Serum Glucose (mg/dL), Median
(IQR)
127 (91–189) 44 (9.1) 164 (107–256) 122 (107–165) 132 (97–201) 127 (96–182) 109 (82–180) 0.051
SOFA score** 5 (3–7) 32
(13.0)
7 (3–9) 5 (4–7) 4 (2–6) 5 (3–7) 6 (3–8) 0.108
Cold exposure 378 (78.6) 13 (2.7) 51 (89.5)a 34 (94.4)b 90 (86.5)c 134 (76.6) 69 (63.3)a, b, c < 0.001
Associated condition
Internal disease 248 (51.6) 0 (0.0) 23 (40.4)a 13 (36.1)b 51 (49.0) 89 (50.9) 72 (66.1)a, b 0.003
Trauma 64 (13.3) 0 (0.0) 5 (8.8) 8 (22.2) 15 (14.4) 23 (13.1) 13 (11.9) 0.452
Alcohol intoxication 43 (8.9) 0 (0.0) 5 (8.8) 2 (5.6) 12 (11.5) 20 (11.4) 4 (3.7) 0.146
Drowning 27 (5.6) 0 (0.0) 8 (14.0)a 3 (8.3) 8 (7.7) 7 (4.0) 1 (0.9)b 0.004
Self-harm 30 (6.2) 0 (0.0) 6 (10.5) 5 (13.9) 9 (8.7) 8 (4.6) 2 (1.8) 0.017
other 126 (26.2) 0 (0.0) 14 (24.6) 7 (19.4) 24 (23.1) 48 (27.4) 33 (30.3) 0.665
Admission ward
No admission 15 (3.1) 0 (0.0) 0 (0.0) 1 (2.8) 4 (3.8) 6 (3.4) 4 (3.7) 0.692
General ward 219 (45.5) 0 (0.0) 25 (43.9) 9 (25.0) 45 (43.3) 82 (46.9) 58 (53.2) 0.056
Intensive care unit 247 (51.4) 0 (0.0) 32 (56.1) 26 (72.2)a 55 (52.9) 87 (49.7) 47 (43.1)a 0.039
Rewarming procedure
Active external or Minimally
invasive
460 (95.6) 0 (0.0) 55 (96.5) 34 (94.4) 98 (94.2) 168 (96.0) 105 (96.3) 0.917
Warm intravenous fluids 360 (74.8) 0 (0.0) 51 (89.5)a 30 (83.3) 83 (79.8)b 130 (74.3) 66 (60.6)a, b < 0.001
Warm blanket 340 (70.7) 0 (0.0) 28 (49.1)a, b 20 (55.6)c 67 (64.0) 137 (78.3)a 88 (80.7)b, c < 0.001
Forced warm air 76 (15.8) 0 (0.0) 13 (22.8)a 9 (25.0) 22 (21.2) 24 (13.7) 8 (7.3)a 0.007
Heating Pads 20 (4.2) 0 (0.0) 4 (7.0) 4 (11.1) 7 (6.7) 2 (1.1) 3 (2.8) 0.009
Warm bath 15 (3.1) 0 (0.0) 3 (5.3) 5 (13.9)a, b 5 (4.8) 1 (0.6)a 1 (0.9)b < 0.001
Active internal 80 (16.6) 0 (0.0) 19 (33.3)a 6 (16.7) 16 (15.4) 28 (16.0) 11 (10.1)a 0.009
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[19, 22]. Cough reflex is obtunded, and ciliary activity is
reduced [1, 8], predisposing to aspiration and pneumo-
nia. Coagulopathy also occurs and is critical for patients
with AH with severe trauma [23, 24]. For patients with
AH, slower RR means prolonged periods of susceptibility
to these potentially harmful physiological effects and
could result in a higher incidence of mortality.
Another outcome of this study is the incidence of VF/
VT. Because VF/VT in patients with AH may be unre-
sponsive to anti-arrhythmic drug and defibrillation [1, 7,
19, 25], they are the most critical complication during
rewarming. Our data showed a positive association be-
tween RR and VF/VT. However, the incidence of VF/VT
was highest in the RR of the 1.5–< 2.0 °C/h group and
not in the fastest RR group. Both rapid rewarming
accompanied by rapid or unpredictable changes in
myocardial temperature and slow rewarming accompan-
ied by prolonged low core body temperature can be the
predisposing factors of VT/VF [26, 27]. These factors
may be counterbalanced, and thus, the occurrence of
VT/VF in our study increased in the high-intermediate
RR group. As the number of patients who presented
with VF/VT was significantly small to draw a conclusion,
further study is required to confirm the association be-
tween RR and the incidence of VF/VT to establish more
appropriate rewarming strategies.
The selection of the rewarming method can vary since
no rewarming method has been proven to be better than
the other rewarming methods. Our study has shown that
regardless of the rewarming method, the RR is asso-
ciated with mortality. It is reasonable to choose active
internal rewarming when rewarming patients is urgent
Table 2 In-hospital data of the study population according to their rewarming rate category (Continued)
All patients Missing Rewarming rate (°C/h) P values*
(≥2.0) (1.5–< 2.0) (1.0–< 1.5) (0.5–< 1.0) (< 0.5)
n = 481 n = 57 n = 36 n = 104 n = 175 n = 109
Lavage 38 (7.9) 0 (0.0) 5 (8.8) 3 (8.3) 11 (10.6) 13 (7.4) 6 (5.5) 0.708
Intravascular 4 (0.8) 0 (0.0) 0 (0.0) 1 (2.8) 0 (0.0) 2 (1.1) 1 (0.9) 0.496
Hemodialysis 25 (5.2) 0 (0.0) 2 (3.5) 1 (2.8) 5 (4.8) 13 (7.4) 4 (3.7) 0.675
ECMO 18 (3.7) 0 (0.0) 13 (22.8)a, b, c 2 (5.6) 1 (1.0)a 1 (0.6)b 1 (0.9)c < 0.001
Other treatment
Intubation 29 (6.03) 0 (0.0) 6 (10.5) 2 (5.6) 6 (5.8) 10 (5.7) 5 (4.6) 0.663
Catecholamine 82 (17.1) 0 (0.0) 16 (28.1) 12 (33.3)a 12 (11.5)a 23 (13.1) 19 (17.4) 0.005
Emergent transvenous cardiac
pacing
6 (1.3) 0 (0.0) 1 (1.8) 2 (5.6) 0 (0.0) 1 (0.6) 2 (1.8) 0.075
Rewarming rate (°C/h), Median
(IQR)†
0.85 (0.53–1.31) 0 (0.0) 2.7 (2.25–3.8) 1.68 (1.6–1.84) 1.20 (1.09–1.31) 0.73 (0.59–0.85) 0.34 (0.25–0.41) < 0.001
Values are expressed as numbers (percentages) unless indicated otherwise
Groups that share a superscript letter were significantly different from post-hoc pairwise comparisons
SOFA sequential organ failure assessment, ECMO extracorporeal membrane oxygenation
* Represents P for heterogeneity across the 5 rewarming rate groups. Comparisons between the 5 groups were evaluated with Kruskal-Wallis test for numeric
variables and Fisher’s exact test for categorical variables. For post-hoc pairwise comparisons of these tests, Steel-Dwass multiple comparison tests and Bonferroni
correction for multiple comparisons were used, respectively
** Calculated with patients admitting to intensive care units
† Post-hoc analysis was omitted
Table 3 In-hospital mortality and the incidence of VF or pulseless VT
All
patients
Rewarming rate (°C/h) Odds for trend P for
trend
(≥2.0) (1.5–< 2.0) (1.0–< 1.5) (0.5–< 1.0) (< 0.5)
n = 481 n = 57 n = 36 n = 104 n = 175 n = 109
Primary outcome
In-hospital mortality 103 (21.4) 11 (19.3) 4 (11.1) 15 (14.4) 35 (20) 38 (34.9)
Odds ratio (95% CI) Reference 0.52 (0.15–1.79) 0.71 (0.30–1.66) 1.05 (0.50–2.24) 2.24 (1.04–4.82) 1.33 (1.10–1.61) 0.003
Adjusted odds ratio (95% CI)* Reference 1.11 (0.27–4.62) 1.23 (0.41–3.66) 1.83 (0.64–5.22) 4.09 (1.33–12.6) 1.49 (1.15–1.94) 0.003
Secondary Outcome
Vf or pulseless VT during rewarming procedure 9 (1.9) 2 (3.5) 2 (5.6) 4 (3.8) 1 (0.6) 0 (0.0)
Odds ratio (95% CI) Reference 1.62 (0.22–12.0) 1.10 (0.20–6.20) 0.16 (0.01–1.78) N/A 0.55 (0.33–0.90) 0.016
Values are expressed as numbers (percentages) unless indicated otherwise
Vf ventricular fibrillation, VT ventricular tachycardia, CI confidence interval
* Adjusted for sex, age category, body temperature at arrival to the hospital, the number of past medical history, activity of daily living, cold exposure, systolic
blood pressure, internal disease etiology, active internal rewarming procedure
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Table 4 In-hospital mortality (subgroup analysis)
All
patients
Rewarming rate (°C/h) Odds for trend P for
trend
(≥2.0) (1.5–2.0) (1.0–1.5) (0.5–1.0) (< 0.5)
n = 481 n = 57 N = 36 n = 104 n = 175 n = 109
Age category
Adults aged 18–64 years 101 15 8 27 35 16
In-hospital mortality 12 (11.9) 1 (6.7) 1 (12.5) 3 (11.1) 5 (14.3) 2 (12.5)
Odds ratio (95% CI) Reference 2.00 (0.11–37.0) 1.75 (0.17–18.5) 2.33 (0.25–21.9) 2.00 (0.16–24.7) 1.17 (0.71–1.95) 0.532
Adjusted odds ratio (95% CI)a Reference N/A N/A N/A N/A 1.69 (0.87–3.30) 0.124
Elderly patients aged ≥65 years 380 42 28 77 140 93
In-hospital mortality (%) 91 (23.9) 10 (23.8) 3 (10.7) 12 (15.6) 30 (21.4) 36 (38.7)
Odds ratio (95% CI) Reference 0.38 (0.10–1.55) 0.59 (0.23–1.51) 0.87 (0.39–1.98) 2.02 (0.89–4.61) 1.33 (1.08–1.64) 0.008
Adjusted odds ratio (95% CI)a Reference 0.68 (0.15–3.17) 0.83 (0.27–2.55) 1.49 (0.51–4.37) 3.68 (1.15–11.8) 1.53 (1.15–2.04) 0.004
Location
Indoor 375 36 27 68 150 94
In-hospital mortality (%) 94 (25.1) 10 (27.8) 3 (11.1) 13 (19.1) 32 (21.3) 36 (38.3)
Odds ratio (95% CI) Reference 0.33 (0.08–1.32) 0.62 (0.24–1.58) 0.71 (0.31–1.61) 1.61 (0.70–3.74) 1.25 (1.01–1.54) 0.039
Adjusted odds ratio (95% CI)b Reference 0.55 (0.11–2.68) 0.89 (0.27–2.87) 1.03 (0.34–3.10) 2.48 (0.76–8.14) 1.36 (1.03–1.80) 0.033
Outdoor 106 21 9 36 25 15
In-hospital mortality (%) 9 (8.5) 1 (4.8) 1 (11.1) 2 (5.6) 3 (12.0) 2 (13.3)
Odds ratio (95% CI) Reference 2.50 (0.14–45.0) 1.18 (0.10–13.8) 2.73 (0.26–28.4) 3.08 (0.25–37.5) 1.32 (0.75–2.32) 0.330
Adjusted odds ratio (95% CI)b Reference N/A N/A N/A N/A 1.98 (0.58–6.76) 0.273
Body temperature at arrival to the hospital
Mild (≥32 °C) 163 10 5 27 60 61
In-hospital mortality (%) 32 (19.6) 0 (0.0) 1 (20.0) 3 (11.1) 6 (10.0) 22 (36.1)
Odds ratio (95% CI) Reference N/A N/A N/A N/A 2.43 (1.38–4.25) 0.002
Adjusted odds ratio (95% CI)c Reference N/A N/A N/A N/A 2.21 (1.15–4.25) 0.017
Moderate (28–32 °C) 216 15 16 48 92 45
In-hospital mortality (%) 45 (20.8) 2 (13.3) 1 (6.2) 6 (12.5) 21 (22.8) 15 (33.3)
Odds ratio (95% CI) Reference 0.43 (0.04–5.35) 0.93 (0.17–5.17) 1.92 (0.40–9.21) 3.25 (0.65–16.3) 1.62 (1.13–2.32) 0.009
Adjusted odds ratio (95% CI)c Reference 0.79 (0.05–11.9) 0.82 (0.12–5.62) 1.69 (0.28–10.2) 2.86 (0.43–18.9) 1.48 (0.96–2.28) 0.078
Severe (< 28 °C) 102 32 15 29 23 3
In-hospital mortality (%) 26 (25.5) 9 (28.1) 2 (13.3) 6 (20.7) 8 (34.8) 1 (33.3)
Odds ratio (95% CI) Reference 0.39 (0.07–2.10) 0.67 (0.20–2.18) 1.36 (0.43–4.32) 1.28 (0.10–15.9) 1.10 (0.76–1.58) 0.612
Adjusted odds ratio (95% CI)c Reference 0.49 (0.07–3.44) 0.58 (0.12–2.90) 1.18 (0.23–6.08) 2.44 (0.13–47.5) 1.17 (0.71–1.93) 0.548
Associated condition
Patients with internal disease etiology 248 23 13 51 89 72
In-hospital mortality (%) 71 (28.6) 5 (21.7) 3 (23.1) 12 (23.5) 22 (24.7) 29 (40.3)
Odds ratio (95% CI) Reference 1.08 (0.21–5.49) 1.11 (0.34–3.62) 1.18 (0.39–3.56) 2.43 (0.81–7.27) 1.29 (1.00–1.65) 0.047
Adjusted odds ratio (95% CI)d Reference 2.04 (0.30–13.8) 1.50 (0.36–6.24) 1.57 (0.40–6.22) 3.48 (0.81–15.0) 1.33 (0.96–1.83) 0.085
Patients without internal disease etiology 233 34 23 53 86 37
In-hospital mortality (%) 32 (13.7) 6 (17.6) 1 (4.3) 3 (5.7) 13 (15.1) 9 (24.3)
Odds ratio (95% CI) Reference 0.21 (0.02–1.89) 0.28 (0.07–1.21) 0.83 (0.29–2.40) 1.50 (0.47–4.78) 1.23 (0.90–1.68) 0.202
Adjusted odds ratio (95% CI)d Reference 0.59 (0.04–8.37) 1.17 (0.14–9.54) 3.96 (0.56–28.2) 10.0 (1.13–88.8) 2.07 (1.23–3.48) 0.006
Rewarming Procedure
Patients with active internal rewarming 80 19 6 16 28 11
In-hospital mortality (%) 21 (26.3) 8 (42.1) 1 (16.7) 2 (12.5) 5 (17.9) 5 (45.5)
Odds ratio (95% CI) Reference 0.28 (0.03–2.83) 0.20 (0.03–1.12) 0.30 (0.08–1.13) 1.15 (0.26–5.11) 0.89 (0.62–1.27) 0.513
Adjusted odds ratio (95% CI)e Reference 0.26 (0.01–5.37) 0.23 (0.01–3.74) 0.33 (0.03–4.44) 3.42 (0.26–45.3) 1.29 (0.71–2.36) 0.408
Patients without active internal rewarming 401 38 30 88 147 98
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because of the haemodynamic instability due to severe
hypothermia [5, 28–31]. However, considering the po-
tential risk of complications with invasive rewarming
methods [1], as well as the insufficient evidence that
these methods improve the outcome in all patients with
severe hypothermia, the best approach, not only for
patient outcomes but also for healthcare cost, may be
the stepwise approach that begins with active external
and minimally invasive rewarming, and saving invasive
method for patients who cannot be rewarmed
adequately.
This study has several limitations. First, this was a
retrospective chart review study; hence, missing data
were unavoidable. A total of 54 patients were excluded
because of missing data, but the number of patients
included in this study is still the largest in this field.
Second, we could not categorise patients whose RR was
over 2.0 °C/h because of the small number of these
patients. Thus, we plan to conduct a prospective study
to obtain a larger number of patients. Third, although
we have adjusted for the possible confounding factors,
there may be residual confounding factors because of
the retrospective design. Fourth, the proportion of ‘cold
exposure’ was approximately 80% in this study. However,
the possibility of underestimation of cold exposure could
not be ruled out because we retrospectively obtained the
data of this registry.
Conclusion
In this study, we found that overall, in-hospital mortality
rates increase with each 0.5 °C/h decrease in RR. How-
ever, judging from the results of subgroup analyses, the
safest RR might differ according to the patient status or
rewarming methods.
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Table 4 In-hospital mortality (subgroup analysis) (Continued)
All
patients
Rewarming rate (°C/h) Odds for trend P for
trend
(≥2.0) (1.5–2.0) (1.0–1.5) (0.5–1.0) (< 0.5)
n = 481 n = 57 N = 36 n = 104 n = 175 n = 109
In-hospital mortality (%) 82 (20.4) 3 (7.9) 3 (10.0) 13 (14.8) 30 (20.4) 33 (33.7)
Odds ratio (95% CI) Reference 1.30 (0.24–6.94) 2.02 (0.54–7.55) 2.99 (0.86–10.4) 5.92 (1.69–20.7) 1.63 (1.27–2.08) < 0.001
Adjusted odds ratio (95% CI)e Reference 1.52 (0.24–9.49) 1.86 (0.43–8.08) 2.91 (0.70–12.1) 6.14 (1.38–27.4) 1.63 (1.19–2.25) 0.002
Values are expressed as numbers (percentages) unless indicated otherwise
aAdjusted for sex, body temperature at arrival to the hospital, the number of past medical history, activity of daily living, cold exposure, systolic blood pressure,
internal disease etiology, active internal rewarming procedure
bAdjusted for sex, age category, body temperature at arrival to the hospital, the number of past medical history, activity of daily living, cold exposure, systolic
blood pressure, internal disease etiology, active internal rewarming procedure
cAdjusted for sex, age category, the number of past medical history, activity of daily living, cold exposure, systolic blood pressure, internal disease etiology, active
internal rewarming procedure
dAdjusted for sex, age category, body temperature at arrival to the hospital, the number of past medical history, activity of daily living, cold exposure, systolic
blood pressure, active internal rewarming procedure
eAdjusted for sex, age category, body temperature at arrival to the hospital, the number of past medical history, activity of daily living, cold exposure, systolic
blood pressure, internal disease etiology
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